Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2011
11/30/2011CN101966245B 一种治疗畜禽病毒性疾病的复方注射液及其制备方法 Compound injection and its preparation method for the treatment of viral diseases of livestock and poultry
11/30/2011CN101961388B 一种预防风热感冒的浴疗泡腾片 A preventive treatment effervescent bath Fengreganmao
11/30/2011CN101934025B 一种用于清热解毒的中药 Chinese medicine for detoxification
11/30/2011CN101933997B 一种复方消炎止痒软膏 A COMPOUND inflammatory anti-itch ointment
11/30/2011CN101829119B 头孢地秦钠组合物及其粉针 Cefodizime sodium composition and powder for injection
11/30/2011CN101822805B 一种治疗乙肝残留黄疸的中药组合物、片剂及制备方法 A residual jaundice hepatitis medicine composition for treatment tablet and preparation method
11/30/2011CN101797263B 一种抗菌消炎的中药组合物 An antimicrobial composition for anti-inflammatory medicine
11/30/2011CN101768139B 哌嗪类衍生物及制备方法和用途 Piperazine derivatives and the preparation and use
11/30/2011CN101766799B 参附蜈蚣保健酒 Shenfu centipede health wine
11/30/2011CN101757106B 一种用于清热解毒的注射液及其制备方法 Injection and its preparation method for detoxification
11/30/2011CN101744824B 头孢硫脒化合物的组合物制剂及其制备方法 The composition and its preparation method cefathiamidine compounds
11/30/2011CN101703601B 预防和治疗鸡败血支原体病的中药组合物及其制备方法 Prevention and treatment of disease Mycoplasma gallisepticum Chinese medicine composition and its preparation method
11/30/2011CN101700290B 一种防治畜禽温热病药物组合物及其制备方法 A pharmaceutical composition of livestock warm disease prevention and preparation method
11/30/2011CN101698011B 治疗畜禽流行性腹泻的药物 Livestock epidemic diarrhea medication
11/30/2011CN101697738B 一种从木醋液中连续提取抗菌物质和抗氧化物质的方法 A method of continuously extracted from wood vinegar antibacterial substances and antioxidants
11/30/2011CN101671638B 一种双歧杆菌新菌株及其发酵制备方法与应用 One kind of Bifidobacterium strains and fermentation new preparation method and application
11/30/2011CN101607081B 布鲁氏菌疫苗及疫苗用抗原蛋白的制备方法 Brucella vaccines and vaccine antigen protein preparation method
11/30/2011CN101580537B 一种人巨细胞病毒ul49基因抗原肽、及其抗体与应用 A human cytomegalovirus gene ul49 antigen peptide, and antibody and application
11/30/2011CN101575365B 一种抗病毒蛋白及其制备方法和应用 An anti-viral protein and its preparation method and application
11/30/2011CN101555266B 一种替比夫定的制备方法 One kind of telbivudine preparation
11/30/2011CN101554376B 一种高生物利用度的雷帕霉素组合物及制备方法 A highly bioavailability rapamycin compositions and methods for preparing
11/30/2011CN101524333B 阿莫西林分散片及其生产方法 Amoxicillin tablet and its production method
11/30/2011CN101502649B 一种脂质体流感疫苗 Liposome influenza vaccine
11/30/2011CN101439187B 胆汁酸-抗肝炎病毒药物偶合物及其制药用途 Bile acid - anti-hepatitis C virus drug conjugate and pharmaceutical use
11/30/2011CN101417008B 作为中兽药复方制剂的注射用双黄连及其制备工艺与应用 SHL injection technology and application in veterinary medicine and its preparation as a compound preparation
11/30/2011CN101199631B 一种含有微粉硅胶的软胶囊及其制备方法 Micronized silica-containing soft capsule and its preparation method
11/30/2011CN101163486B 阿奇霉素在生产用于治疗眼部感染的药物中的用途 Azithromycin use in the manufacture of a medicament for the treatment of eye infections in
11/29/2011US8067674 Desaturase genes, enzymes encoded thereby, and uses thereof
11/29/2011US8067606 Gyrase inhibitors and uses thereof
11/29/2011US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011US8067569 Splice-region antisense composition and method
11/29/2011US8067438 Hepatitis C inhibitor compounds
11/29/2011US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011US8067385 Antiviral oligonucleotides targeting HBV
11/29/2011US8067016 Fusion proteins of Mycobacterium tuberculosis
11/29/2011US8067015 Delivery device for topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration coated with a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance
11/29/2011US8067010 Immunological herpes simplex virus antigens and methods for use thereof
11/29/2011US8067004 Surface antigen
11/29/2011US8066992 Medicament and a method of treating a pathological syndrome
11/29/2011US8066985 Reovirus for the treatment of cellular proliferative disorders
11/29/2011CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011CA2621066C Method for treatment or prevention of conditions caused by gram-positive bacteria
11/29/2011CA2611520C Method and composition for pharmaceutical product
11/29/2011CA2525657C Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats o6 of pseudomonas aeruginosa
11/29/2011CA2507502C Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists
11/29/2011CA2473634C 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
11/29/2011CA2470447C Streptogramin derivatives, preparation thereof and compositions containing same
11/29/2011CA2448208C Influenza vaccine composition
11/29/2011CA2442909C Multimerization of hiv-1 vif protein as a therapeutic target
11/29/2011CA2438524C Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
11/29/2011CA2414331C Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/29/2011CA2401241C 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
11/29/2011CA2380359C Process for producing benzoxazine derivative and production intermediate thereof
11/29/2011CA2366541C Novel recombinant and mutant herpesviruses
11/24/2011WO2011146891A2 High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins
11/24/2011WO2011146817A1 Heterocyclic flaviviridae virus inhibitors
11/24/2011WO2011146401A1 Novel inhibitors of hepatitis c virus replication
11/24/2011WO2011146255A1 Combination therapy for the treatment of bacterial infections caused by acinetobacter baumannii
11/24/2011WO2011145765A1 Skin preparation composition for external use with excellent antibacterial and antifungal effects
11/24/2011WO2011144924A1 Amine or amid analogues of sanglifehrin
11/24/2011WO2011144655A1 Process for the preparation of chiral hydrazides
11/24/2011WO2011144653A1 Process for the preparation of chiral triazolones
11/24/2011WO2011144517A1 Furin and biologically active derivatives thereof for use in the prevention or treatment of an inflammatory disease
11/24/2011WO2011144054A1 Dibenzocyclooctene lignan derivatives and uses thereof in treatment of viral hepatitis
11/24/2011WO2011144021A1 Cefpiramide sodium hydrate, preparation method and uses thereof
11/24/2011WO2011143935A1 Crystalline of carbapenem derivative or its hydrate, preparation methods and uses thereof
11/24/2011WO2011143932A1 Aromatic butan-2-ol compounds, preparation methods and uses thereof
11/24/2011WO2011143844A1 Traditional chinese medicine composition for treating infection of influenza a virus subtype and preparation method thereof
11/24/2011WO2011143772A1 Inhibitors of hiv replication
11/24/2011WO2011110671A3 Pharmaceutical composition for the treatment of chlamydial infection
11/24/2011WO2011100698A3 Methods of treating viral infection
11/24/2011WO2011087934A3 Kexin-derived vaccines to prevent or treat fungal infections
11/24/2011WO2011087494A3 Use of a virucidal preparation on an area of the face for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses
11/24/2011WO2011085070A3 Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts
11/24/2011WO2011082422A3 Human immunodeficiency virus (hiv-1) highly conserved and low variant sequences as targets for vaccine and diagnostic applications
11/24/2011WO2011060431A3 Multivalent live vector vaccine against clostridium difficile-associated disease
11/24/2011WO2011036558A3 Crystalline methylthionium chloride (methylene blue) hydrates
11/24/2011WO2011036159A3 Treatment and prevention of hiv infection
11/24/2011US20110289606 Equine disease model for herpesvirus neurologic disease and uses thereof
11/24/2011US20110288164 Agent for inhibiting production of hepatitis c virus and its use
11/24/2011US20110288161 Methods for treatment of thiol-containing compound deficient conditions
11/24/2011US20110288159 Methods of expressing a polypeptide in the brain and nucleic acid constructs capable of same
11/24/2011US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011US20110288148 Triggered covalent probes for imaging and silencing genetic expression
11/24/2011US20110288147 Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop
11/24/2011US20110288136 Flavivirus inhibition by sultams and related compounds
11/24/2011US20110288130 Bacterial thioredoxin reductase inhibitors and methods for use thereof
11/24/2011US20110288111 Inhibition of influenza m2 proton channel
11/24/2011US20110288109 New compounds
11/24/2011US20110288103 Compounds, compositions, and methods comprising 1,3,4-oxadiazole derivatives
11/24/2011US20110288095 Thiophene-carboxamides useful as inhibitors of protein kinases
11/24/2011US20110288088 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
11/24/2011US20110288084 [4-( 1-amino-ethyl) - cyclohexyl ] - methyl - amines as antibacterials
11/24/2011US20110288077 Compounds for the treatment of inflammatory diseases
11/24/2011US20110288071 Substituted pyrimidines for the treatment of diseases such as cancer
11/24/2011US20110288063 Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
11/24/2011US20110288060 apparatus and process for producing crystals
11/24/2011US20110288053 Antiviral phosphonate analogs
11/24/2011US20110288052 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/24/2011US20110288049 Compositions, Systems, and/or Methods Involving Chlorine Dioxide ("ClO2")